Related references
Note: Only part of the references are listed.A Large Cross-Sectional Survey Study of the Prevalence of Alopecia Areata in the United States
Michael Benigno et al.
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2020)
Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata
Julian Mackay-Wiggan et al.
JCI INSIGHT (2016)
Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
Ali Jabbari et al.
EBIOMEDICINE (2015)
Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
Brittany G. Craiglow et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Psychiatric symptomatology and health-related quality of life in children and adolescents with alopecia areata
O. Bilgic et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2014)
Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
Luzhou Xing et al.
NATURE MEDICINE (2014)
The Relationship Between Alopecia Areata and Alexithymia, Anxiety and Depression: A Case-control Study
Rim Sellami et al.
INDIAN JOURNAL OF DERMATOLOGY (2014)
Development of the Alopecia Areata Symptom Impact Scale
Tito R. Mendoza et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2013)
Janus kinases in immune cell signaling
Kamran Ghoreschi et al.
IMMUNOLOGICAL REVIEWS (2009)
Alopecia areata investigational assessment guidelines - Part II
EA Olsen et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
Share Paper
